Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...

Assessment for cognitive impairment can be performed at any visit, but is a required component of the Medicare Annual Wellness Visit. If your primary care doctor observes a memory deficit, he or she ...

Dr Lotte Knudson, a scientist from Copenhagen, revolutionized research into drugs used by millions to lose weight. She has ...

Let’s spill the facts: medications like semaglutide (sold as Ozempic and Wegovy) and tirzepatide (known as Zepbound and Mounjaro) have totally transformed the weight loss game. These injectables ...

According to a GP, there are some early signs of dementia that may be noticeable even before memory loss. Dementia is a ... the condition quickly so that a treatment plan and medications can ...

Alzheimer's disease (AD) is a progressive brain disorder that gradually destroys memory and cognitive abilities, affecting ...

Physicians are increasingly using weight loss drugs to treat obesity ... And then we get to go wait. The data in adults show that if you don't lose at least 15 percent of your weight on ...

Novo and rival Eli Lilly, which makes the GLP-1 weight-loss drug Zepbound ... Others were taking older Novo drugs Saxenda or Victoza, which are both liraglutide, Rybelsus, an oral version of ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A study published in Alzheimer's & Dementia reveals semaglutide lowers ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy ... from more than 17 million adults, Mass General Brigham ...

But are they right for you, especially if you're older than the average user? By Hallie Levine Are you wondering whether you’re a candidate for one of the newer weight loss drugs, semaglutide ...

Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new tally finds. Advertisement "In contrast, there was a 25.6% decrease in ...